Diabetes care: First drug to delay onset of type 1 diabetes made available on NHS
In a landmark announcement, the NHS has introduced a beacon of hope for individuals susceptible to type 1 diabetes.
Teplizumab, an innovative medication, is now able to delay the disease's onset for an average of three years, focusing on the autoimmune process impacting the pancreas.
This breakthrough provides vital time for young patients, allowing them to manage their health more effectively before the disease fully manifests.
NHS Approves First Drug to Delay Type 1 Diabetes
- First drug to delay onset of type 1 diabetes made available on NHS BBC News —
- 'First of its kind' drug that delays type 1 diabetes by up to three years is approved by the NHS Daily Mail —
- One in five Brits back 'fat jab menus' at restaurants as Ozempic-style drugs change how we eat, study reveals Daily Mail —
- Ground-breaking drug which can hold off diabetes for three years approved for NHS use LBC —
- First drug to slow type 1 diabetes approved for NHS use in 'landmark' moment Manchester Evening News —